Who
Quan Anh Vu
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Monopar Therapeutics; COO / Chief Business Officer, Forum Markets.
In numbers
- Trades disclosed
- 16
- Buys
- 3
- Sells
- 0
- Bought
- $154K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 8 Dec 2021
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | —614 | filing |
| 30 Sep 2026filed 2 Oct 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code F | $14K180 at $79.67 | filing |
| 30 Sep 2026filed 2 Oct 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —614 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,228 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code F | $47K507 at $92.59 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,228 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,228 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,228 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code F | $47K507 at $92.59 | filing |
| 26 Dec 2025filed 29 Dec 2025 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Bought | $105K1,500 at $69.95 | filing |
| 2 Dec 2025filed 8 Dec 2025 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,135 at $0.00 | filing |
| 2 Dec 2025filed 8 Dec 2025 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,826 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 16 Dec 2021filed 16 Dec 2021 | FRMM Forum MarketsConsumer & Specialty Finance | SEC FORM 4 Bought | $32K8,000 at $3.98 | filing |
| 10 Dec 2021filed 10 Dec 2021 | FRMM Forum MarketsConsumer & Specialty Finance | SEC FORM 4 Bought | $18K4,500 at $3.90 | filing |
| 8 Dec 2021filed 10 Dec 2021 | FRMM Forum Marketsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —275,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.